UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000021813
Receipt No. R000024452
Scientific Title A phase III study comparing nivolumab with nivolumab plus docetaxel in patients with previously treated advanced non-small-cell lung cancer: a randomized phase II/III trial(TORG1630)
Date of disclosure of the study information 2016/05/01
Last modified on 2020/10/10 11:35:20

No. Disposal Last modified on Item of update
1 Insert 2016/04/07 10:21:41
2 Update 2016/04/07 10:26:48 Email
3 Update 2016/05/09 09:22:00 Anticipated trial start date
4 Update 2016/08/17 15:21:50 Organization
Organization
5 Update 2016/10/11 15:04:27 Anticipated trial start date
6 Update 2016/10/11 15:04:27 Anticipated trial start date
7 Update 2017/02/03 20:43:05 Public title
Public title
Acronym
Acronym
8 Update 2017/02/03 20:54:36 Developmental phase
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
9 Update 2017/02/03 20:56:52 Anticipated trial start date
10 Update 2017/02/03 20:57:39 Date of protocol fixation
11 Update 2017/04/23 09:05:22 Anticipated trial start date
12 Update 2017/12/11 09:27:05 Recruitment status
Anticipated trial start date
13 Update 2018/04/10 15:17:13 Anticipated trial start date
14 Update 2019/04/10 09:45:49 Date of IRB
Last follow-up date
15 Update 2019/11/12 09:50:57 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
16 Update 2020/07/13 16:42:53 Recruitment status
17 Update 2020/10/10 11:35:20 Number of participants that the trial has enrolled


Contact us.